Azilsartan medoxomil monopotassium (TAK-491; TAK491; Edarbi), the monopotassium salt of Azilsartan medoxomil which is a prodrug of azilsartan, is an angiotensin II receptor (AT1) type 1 antagonist approved as an anti-hypertensive medication to lower blood pressure.

AVE0991 sodium, the sodium salt of AVE-0991, is a novel, orally bioactive non-peptide mimic and high affinity agonist of angiotensin-(1-7) with an IC50 of 21 nM.

AT2 Agonist C21 (M-24) is a novel, potent and selective agonist of angiotensin AT2 receptors with Ki values of 0.4 nM and >10 µM for the AT2 receptor and AT1 receptor, respectively.

Losartan D4 (also called DuP753 D4; DuP-753 D4) is the tetra-deuterated form of losartan (Cozaar among others), which is an angiotensin II receptor antagonist and antihypertensive drug.

Azilsartan mepixetil is a prodrug of azilsartan which is an antagonist of angiotensin II receptor with antihypertensive, renal and cardioprotective effects.

Angiotensin acetate is a novel and potent angiotensin II analogue.

CGP-42112(also known as CGP-42112A) is a novel, potent and selective Angiotensin-II subtype 2 receptor(AT2 R) agonist.

Candesartan D4 (CV-11974 D4) is the tetra-deuterated form (in the central phenyl ring) of form of Candesartan (formerly TCV-116; CV-11974; Atacand), which is an angiotensin II receptor antagonist (AT II inhibitor) approved for treating hypertension and congestive heart failure.

Eprosartan (formerly SKF-108566J; SKF108566; SKF 108566; Teveten; Futuran; Navixen; Regulaten) is a nonpeptide angiotensin II receptor antagonist that has been approved as an antihypertensive medication for the treatment of high blood pressure.

Losartan carboxylic acid (EXP-3174; EXP 3174; EXP3174) is a cytochrome P450-mediated carboxylic acid metabolite, and is an active metabolite of Losartan.